|
Market Closed -
NYSE
04:00:02 2026-10-20 pm EDT
|
5-day change | 1st Jan Change | ||
| 23.75 USD | +7.27% |
|
+5.51% | -0.34% |
| 05:41am | Wedbush Adjusts Price Target on Arcus Biosciences to $49 From $43, Keeps Outperform Rating | MT |
| Oct. 20 | Arcus Biosciences, Inc. - Special Call |
| Market Cap | 3.02B 2.69B 2.49B 2.26B 4.25B 286B 4.32B 29.93B 11.76B 150B 11.34B 11.11B 478B | P/E 2026 * |
-6.72x | P/E 2027 * | -7.15x |
|---|---|---|---|---|---|
| Enterprise Value | 2.58B 2.3B 2.13B 1.93B 3.63B 245B 3.69B 25.57B 10.05B 128B 9.69B 9.49B 409B | EV / Sales 2026 * |
34.8x | EV / Sales 2027 * | 50.7x |
| Free-Float |
71.2% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| RCUS | Delayed | |
CBOE
| RCUS | Real-time |
Last Transcript: Arcus Biosciences, Inc.
| 1 day | +7.27% | ||
| 1 week | +5.51% | ||
| Current month | -8.05% | ||
| 1 month | -5.90% | ||
| 3 months | -15.69% | ||
| 6 months | +4.44% | ||
| Current year | -0.34% |
| 1 week | 20.81 |  | 24.7 |
| 1 month | 20.81 | | 27.9 |
| Current year | 18.52 | | 31.74 |
| 1 year | 16.41 | | 31.74 |
| 3 years | 6.5 | | 31.74 |
| 5 years | 6.5 | | 49.1 |
| 10 years | 6.3 | | 49.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Juan Jaen
PSD | President | 68 | 2015-04-30 |
Terry Rosen
CEO | Chief Executive Officer | 67 | 2015-04-30 |
Robert Goeltz
DFI | Director of Finance/CFO | 53 | 2020-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Terry Rosen
CHM | Chairman | 67 | 2017-11-30 |
Kathryn Falberg
BRD | Director/Board Member | 65 | 2017-09-17 |
Yasunori Kaneko
BRD | Director/Board Member | 72 | 2015-04-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/21/26 | Exercice | Controller/Auditor | 8,481 | 0.0067% | ||
| 7/10/26 | Sell | Founder | -20,067 | 0.0160% | ||
| 6/11/26 | Free | Director | 22,600 | 0.0180% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.27% | +5.51% | +35.95% | +47.33% | 3.02B | |
| +0.79% | -6.16% | +49.32% | +74.50% | 66.34B | |
| -0.51% | +6.08% | +11.21% | +89.56% | 52.92B | |
| +0.33% | +4.90% | +7.53% | +73.61% | 54.82B | |
| +0.74% | +2.75% | +26.31% | +45.29% | 44.09B | |
| +3.87% | +10.15% | +20.69% | +132.73% | 43.72B | |
| +7.91% | +4.30% | +263.91% | +602.72% | 42.13B | |
| -0.40% | +9.85% | +17.04% | +59.17% | 33.96B | |
| -1.30% | -0.68% | +37.15% | +7.04% | 26.17B | |
| +0.52% | +5.76% | +36.81% | +26.58% | 23.37B | |
| Average | +1.92% | +5.02% | +50.59% | +115.85% | 39.05B | |
| Weighted average by Cap. | +1.45% | +4.85% | +51.16% | +127.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 74.3M 66.13M 61.29M 55.54M 104M 7.04B 106M 735M 289M 3.68B 279M 273M 11.75B | 57.68M 51.34M 47.58M 43.12M 81.04M 5.46B 82.39M 571M 224M 2.86B 216M 212M 9.12B |
| Net income | -447M -398M -369M -334M -628M -42.34B -638M -4.42B -1.74B -22.16B -1.68B -1.64B -70.68B | -418M -372M -345M -312M -587M -39.56B -597M -4.13B -1.62B -20.7B -1.57B -1.53B -66.05B |
| Net Debt | -441M -392M -364M -329M -619M -41.74B -629M -4.36B -1.71B -21.85B -1.65B -1.62B -69.69B | -102M -90.93M -84.28M -76.37M -144M -9.68B -146M -1.01B -397M -5.06B -383M -375M -16.16B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-20 | $23.75 | +7.27% | 6,242,268 |
| 26-10-19 | $22.14 | +0.09% | 3,516,696 |
| 26-10-16 | $22.12 | -3.07% | 1,425,533 |
| 26-10-15 | $22.82 | +1.29% | 1,210,181 |
| 26-10-14 | $22.53 | +0.09% | 1,211,971 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RCUS Stock
Select your edition
All financial news and data tailored to specific country editions
